Antitrombin, COVID-19 ve Taze Dondurulmuş Plazma Tedavisi

Kaynakça (7)

1. . Anaklı İ, Ergin Özcan P, Polat Ö, Orhun G, Alay GH, Tuna V, Çeliksoy E, Kılıç M, Mercan M, Ali A, Beşışık S, Esen F. Prognostic value of antithrombin levels in COVID-19 patients and impact of fresh frozen plasma treatment: a retrospective study. Turk J Hematol 2021
2. Bajpai M, Kumar S, Maheshwari A, Chhabra K, Kale P, Gupta A, Narayanan A, Gupta E, Trehanpati N, Bihari C, Agarwal R, Gupta K, Gupta UK, Bhardwaj A, Kumar G, Islam M, Singh R, Yadav P, Maiwall R, Sarin SK. Efficacy of convalescent plasma therapy compared to fresh frozen plasma in severely ill COVID-19 patients: a pilot randomized controlled trial. medRxiv Preprints. Available at https://doi.org/10.1101/2020.10.25.20219337. 3. Joob B, Wiwanitkit V. Convalescent plasma and covid-19 treatment. Minerva Med (in press). 4. Iba T, Levy JH, Levi M, Thachil J. Coagulopathy in COVID-19. J Thromb Haemost 2020
3. Tabibi S, Tabibi T, Conic RRZ, Banisaeed N, Streiff MB. Therapeutic plasma exchange: a potential management strategy for critically ill COVID-19 patients. J Intensive Care Med 2020
4. 835 4. Fernandez J, Gratacos-Ginès J, Olivas P, Costa M, Nieto S, Mateo D, Sánchez MB, Aguilar F, Bassegoda O, Ruiz P, Caballol B, Pocurull A, Llach J, Mustieles MJ, Cid J, Reverter E, Toapanta ND, Hernández-Tejero M, Martínez JA, Claria J, Fernández C, Mensa J, Arroyo V, Castro P, Lozano M
5. Covid Clinic Critical Care (CCCC) Group. Plasma exchange: an effective rescue therapy in critically ill patients with coronavirus disease 2019 infection. Crit Care Med 2020
6. e1350-e1355. 5. Von Bahr V, Millar JE, Malfertheiner MV, Ki KK, Passmore MR, Bartnikowski N, Redd MA, Cavaye M, Suen JY, McAuley DF, Fraser JF. Mesenchymal stem cells may ameliorate inflammation in an ex vivo model of extracorporeal membrane oxygenation. Perfusion 2019
7. World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard. Geneva, WHO, 2021. Available at https://covid19.who.int/.